Research And Views Archives | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Archives... Don't Miss Anything, Ever!

Here you will find all the research and views that we post on Equitymaster. Use the tools to customize the results to suit your preference!


Orchid Pharma: Cephalosporin drives growth

Dec 26, 2003

Orchid Chemicals & Pharmaceuticals (OCP) is mainly into the manufacture of bulk drugs, formulations and nutraceuticals. The company is the largest manufacturer and exporter of cephalosporin bulk drugs in India and is amongst the top five producers in the world. OCP recently announced its September quarter results. The company has emerged as a preferred choice for Cephalosporin bulk drug, and is reaping the benefits of the same. The company reported a 45% growth in topline and a robust 153% botto

Operating margins under pressure at Orchid Pharma

Jan 29, 2000

Orchid is a bulk drug manufacturer. The company's primary products are oral and sterile cephalosporins -cephalexin, cefradine and cefradroxyl. For the quarter ended December 1999 Orchid has reported a 38.7% jump in the topline. The operating margins excluding other income are under pressure. This has led to only a 19.3% jump in the bottomline. The company made placement of 10.7 million shares at Rs.175/ per share to Schroder Capital during the year.

Orchid takes over Ajanta bulk drug plant

Jan 5, 2000

Orchid Chemicals is acquiring the bulk drug facility of Ajanta Pharmaceuticals. The price tag that the company is to pay for the Aurangabad based plant has been fixed at Rs 210 m.

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms